Harvard Bioscience Buys Preclinical Unit of CMA Microdialysis
Filed in archive Biotech/Science Blogs on July 7, 2011

© Idaho National LaboratoryHarvard Bioscience has taken over CMA Microdialysis' preclinical unit. Harvard Bioscience, also known as HBIO is the producer, marketer and developer of scientific apparatus and other specialized goods. They took over the preclinical unit of the company by way of purchasing assets. CMA Microdialysis is a Swedish company- founded in 1984- which is a market leader in the manufacture of microdialysis products.
Since Harvard Bioscience is a market leader when it comes to providing tools for research and other such purposes, this acquisition implies a good future. According to Chane Graziano, CEO of Harvard Bioscience, this new acquisition will bring a lot of positives for Harvard Bioscience as it will add to their products. The business unit will remain in Sweden though.
According to Philip Siberg, CEO of CMA Microdialysis, Harvard Bioscience will be allowed to name the preclinical unit; and because of that, it will now be called, Dipylon Medical AB and will continue to market microdialysis products.

© Idaho National Laboratory
comment!
(0)
(0)
vote!
(9.3/10)
(9.3/10)
e-mail!
Bookmark
|
|
Mr Wong
|
|

Mr Wong
